Category: Press Releases

LCC Hackathon

Solve Aging and Enhance Brains at MIT This Week!

It might take a second renaissance bringing polymaths across science to solve aging and enhance human mental capacity to groundbreaking heights. This week’s Longevity, Computing, and Cognition Research Hackathon at

Frontier Bio

Lab-Grown Lung Tissue for Diseases and Transplants

Frontier Bio Corporation has announced a groundbreaking achievement in lab-grown lung tissue. By combining 3D bioprinting with the ability of stem cells to self-assemble, mimicking natural organ development, the California-based

Lifespan Research Institute

lifespan.io and SENS Research Foundation Unite

October 1, 2024 – lifespan.io (Lifespan Extension Advocacy Foundation) and SENS Research Foundation are excited to announce the completion of their merger, forming a new 501(c)(3) non-profit: Lifespan Research Institute.

Insilico Medicine

Insilico Medicine Reports Positive Phase IIa Results for IPF

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its Phase IIa clinical trial evaluating ISM001-055. ISM001-055 is a first-in-class small molecule targeting TNIK (Traf2-

Ora Biomedical

Ora Biomedical Awarded Technology Development Grant

Ora Biomedical, Inc., a pioneering longevity biotechnology company, is pleased to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Institutes

Xplore Program

Young Longevity Talent from the 2024 Xplore Program

LongX, an initiative dedicated to providing global early-career avenues into longevity, has concluded Cohort 1 of its first fully remote educational venture, the Xplore Program. The longevity community is welcome

A4LI Logo

A4LI Responds to NIH Reform Proposal

August 5, 2024 WASHINGTON, DC — The Alliance for Longevity Initiatives (A4LI) is proposing a new National Institute for Longevity and Aging Research (NILAR) in response to the recent NIH

Rejuve.ai logo

20 Global Partners Pledge to Lengthen Human Lifespans

Today, Rejuve.AI, the world’s first decentralized AI longevity research network, has announced four new partnerships, bringing the grand total to 20 organizations that have committed alongside Rejuve.AI to help humankind

Turn.bio logo

Turn Bio Signs Agreement with HanAll Biopharma

Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an exclusive global licensing agreement with pharmaceutical manufacturer HanAll Biopharma to develop groundbreaking medicines for the treatment

LCC Hackathon

Solve Aging and Enhance Brains at MIT This Week!

It might take a second renaissance bringing polymaths across science to solve aging and enhance human mental capacity to groundbreaking heights. This week’s Longevity, Computing, and Cognition Research Hackathon at MIT tackles this initiative. From 10/25 to 10/27, Ekkolápto, Augmentation Lab, and Meditation Artifacts will unite

Frontier Bio

Lab-Grown Lung Tissue for Diseases and Transplants

Frontier Bio Corporation has announced a groundbreaking achievement in lab-grown lung tissue. By combining 3D bioprinting with the ability of stem cells to self-assemble, mimicking natural organ development, the California-based biotech company has created complex microscale lung tissue. This innovation paves the way for advancements in

Lifespan Research Institute

lifespan.io and SENS Research Foundation Unite

October 1, 2024 – lifespan.io (Lifespan Extension Advocacy Foundation) and SENS Research Foundation are excited to announce the completion of their merger, forming a new 501(c)(3) non-profit: Lifespan Research Institute. Lifespan Research Institute (“LRI”) will develop, promote, and ensure widespread access to regenerative medicine solutions targeting

International Institute of Longevity

Insights from the Roundtable of Longevity Clinics 2024

The quest to extend human lifespan and improve healthspan is advancing rapidly, and one of the most prestigious platforms for driving these discussions is the Roundtable of Longevity Clinics. This annual gathering brings together global experts to exchange knowledge on cutting-edge research, innovations, and regulatory strategies

BOAC logo

Biomarkers of Aging Consortium Announces Second Conference

The Biomarkers of Aging Consortium is proud to announce its second annual Biomarkers of Aging Conference, scheduled for November 1-2, 2024, at the Joseph Martin Conference Center at Harvard Medical School. This event stands as the premier conference dedicated to all aspects of biomarkers of aging,

Insilico Medicine

Insilico Medicine Reports Positive Phase IIa Results for IPF

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its Phase IIa clinical trial evaluating ISM001-055. ISM001-055 is a first-in-class small molecule targeting TNIK (Traf2- and Nck-interacting kinase) and was designed utilizing generative AI to treat idiopathic pulmonary fibrosis (IPF). The

Ora Biomedical

Ora Biomedical Awarded Technology Development Grant

Ora Biomedical, Inc., a pioneering longevity biotechnology company, is pleased to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Institutes of Health (NIH). The $324,240 grant will support the development of EleGantry, an innovative software and

Xplore Program

Young Longevity Talent from the 2024 Xplore Program

LongX, an initiative dedicated to providing global early-career avenues into longevity, has concluded Cohort 1 of its first fully remote educational venture, the Xplore Program. The longevity community is welcome to attend the Xplore Program showcase event on Sep 7, 2024 to support the next generation

TimePie Header

40+ Experts Gather in Shanghai for TimePie Longevity Forum

From November 1st to 3rd, 2024, the 5th TimePie Longevity Forum will take place in Shanghai, China. Bringing together 40+ leading speakers from around the globe and attracting over 1,000 attendees, this event is set to be one of the most significant platforms for international anti-aging

A4LI Logo

A4LI Responds to NIH Reform Proposal

August 5, 2024 WASHINGTON, DC — The Alliance for Longevity Initiatives (A4LI) is proposing a new National Institute for Longevity and Aging Research (NILAR) in response to the recent NIH reform proposed by House Energy and Commerce (E&C) Chair Cathy McMorris-Rodgers (R-WA). While this new NIH

Fatty15

Clinical Trial Reveals a Foe of Fatty Liver Disease

A highly anticipated clinical trial was just published by the prestigious Journal of Nutrition with a surprising finding: that C15:0, a trace dietary saturated fat present in butter, can lower liver enzymes in young adults susceptible to fatty liver disease. Nonalcoholic fatty liver disease (NAFLD), also

ARDD2024

Aging Research & Drug Discovery Sold Out – What to Expect

On July 26, 2024, the 11th Aging Research and Drug Discovery meeting had to stop registrations after reaching full capacity. It sold out two weeks faster than in 2023, a month prior to the start of the conference. The conference is a non-profit volunteer-run event organized

Rejuve.ai logo

20 Global Partners Pledge to Lengthen Human Lifespans

Today, Rejuve.AI, the world’s first decentralized AI longevity research network, has announced four new partnerships, bringing the grand total to 20 organizations that have committed alongside Rejuve.AI to help humankind live longer. Rejuve.AI is working to lengthen lifespans by paying members in its RJV crypto token

Turn.bio logo

Turn Bio Signs Agreement with HanAll Biopharma

Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an exclusive global licensing agreement with pharmaceutical manufacturer HanAll Biopharma to develop groundbreaking medicines for the treatment of age-related eye and ear conditions. The agreement, potentially exceeding $300 million in value for the first of

Ora Biomedical

Ora Biomedical and Air Force Partner for Therapies

Ora Biomedical, Inc. announces it has been selected by AFWERX for a SBIR Phase I contract in the amount of $75,000 focused on developing novel therapeutics to address the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and